Allergy

Additionally, investigators believe epidermal impairment in the skin of children with atopic dermatitis could contribute to the development of allergic sensitization.

Investigators believe these findings can help identify high-risk groups and prevent exacerbations through tailored treatments.

An Australian study used data consistent with international literature on the subject of de-labeling penicillin for low-risk allergy patients.

Investigators report that few medical schools in Europe consider allergology to be an important area of study, resulting in a lack of knowledge regarding certain allergy practices.

In an interview with HCPLive, Rosenberger mentioned that every conversation with a patient is an opportunity to educate them on their potential allergies and treatment methods, especially at a time when concerns regarding the delta variant are prominent.

Investigators believe the ALDORADO trial could properly diagnose the accuracy of open food challenges in comparison to the traditionally used double-blind placebo-controlled food challenge in pediatric patients with food allergies.

Investigators report that the small number of adverse events from the vaccine were successfully treated, with the remaining participants experiencing no allergic responses.

The investigative team in Canada found that pre-pregnancy weight may possibly influence a child’s risk of developing pediatric allergic diseases.

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators found that children with antibiotic allergy labels have longer hospital stays and increased symptoms of allergic reaction.

Investigators link early atopic manifestations and other complications to tree nut allergy, which account for most of all food related deaths by anaphylaxis.

Staff from schools across the United Kingdom express desire for enhanced staff preparedness and internal allergy policy review after being surveyed by investigators.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.

A new multi-year study shows that the immunotherapy increases tolerance of peanut products in patients with allergies.

Researchers report antibody responses in kidney transplant recipients and the impact of specific regiments utilized by select patients.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

Researchers in North Carolina recorded improvements in pediatric healthcare utilization partly attributed to a lack of exposure to allergens and other exacerbations.

Using a participant group culled from several countries, investigators believe they have a better understanding on what contributes to uncontrolled allergic rhinitis and what it means for future patient care.

The new kinoid vaccine has shown positive results in mice with human proteins, and the France-based team remain optimistic of human trials in the future.

Researchers in the UK recommend early detection and treatment of food allergy and sensitization to avoid complications in adulthood.

Post-survey responses show educators were eager to learn more about how to prevent students from experiencing food-anaphylactic reactions.

Investigators recorded a significant decrease in disease-specific anxiety in parents and children provided online therapy.

A new study builds upon previous insights and contributes to the growing trend of probiotic treatment in young patients.

The first-in-class indication allows for patients to switch from partial-prescription use to over-the-counter with azelastine hydrochloride nasal spray.

The monoclonal antibody has proved effective in combatting the spread of fibrocytes in asthmatic individuals.

Researchers urge parents and doctors to take a closer look at the common disease and its possible more severe subtypes.

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

David I. Bernstein, MD of the University of Cincinnati College of Medicine discusses the recent approval of short ragweed pollen allergen extract tablet (RAGWITEK) for the treatment of children and adolescents.